Authors: Authors/Task Force Members, A. John Camm, Gregory Y.H. Lip, Raffaele De Caterina, Irene Savelieva, Dan Atar, Stefan H. Hohnloser, Gerhard Hindricks, Paulus Kirchhof, Jeroen J. Bax, Helmut Baumgartner, Claudio Ceconi, Verónica Dean, Christi Deaton, Robert Fagard, Christian Funck‐Brentano, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa A. McDonagh, Cyril Moulin, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Michal Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Document Reviewers, Panos Vardas, Nawwar Al-Attar, Ottavio Alfieri, Annalisa Angelini, Carina Blömstrom-Lundqvist, Paolo Colonna, Johan De Sutter, Sabine Ernst, Andreas Goette, Bülent Görenek, Róbert Hatala, Hein Heidbüchel, Magnus Heldal, Steen Dalby Kristensen, Philippe Kolh, Jean‐Yves Le Heuzey, Hercules E. Mavrakis, Lluı́s Mont, Pasquale Perrone Filardi, Piotr Ponikowski, Bernard Prendergast, Frans H. Rutten, Ulrich Schotten, Isabelle C. Van Gelder, Freek W.A. Verheugt - EP Europace 2012 cited by 3,832
Atrial fibrillation; European Society of Cardiology; Guidelines; Anticoagulation; Novel oral anticoagulants; Left atrial appendage occlusion; Rate control; Cardioversion; Rhythm control; Antiarrhythmic drugs; Upstream therapy; Pulmonary vein isolation; Left atrial ablation; Focused update; RANDOMIZED CONTROLLED-TRIAL; HEART RHYTHM ASSOCIATION; NET CLINICAL BENEFIT; RE-LY TRIAL; STROKE RISK STRATIFICATION; ACUTE CORONARY SYNDROME; RADIOFREQUENCY CATHETER ABLATION; ANTIARRHYTHMIC-DRUG THERAPY; ORAL ANTICOAGULANT DRUGS; NORMALIZED RATIO CONTROL
